Skip to main content

Combined Anti-diabetic Effects of Extracts of Artemisia annua var. Chiknensis (CBGE/CHNA/09/LTNGS/G) and Each of Three Other Plants (Momordica charantia Linn. Vernonia amygdalina Del. and Aegle marmelos Correa) Traditionally Used in Nigeria for the Treatment of Diabetes | Chapter 11 | Advances in Applied Science and Technology Vol. 6

The combined anti-diabetic effects of Extracts of Artemisia annua var. chiknensis with Laboratory code number (CBGE/CHINA/09/LTNGS/G), Momordica charantia Linn, Vernonia amygdalina Del. and Aegle marmelos Correa traditionally employed in Nigeria for the treatment of diabetes were studied. Fifty male albino rats which had been subjected to overnight fasting were rendered diabetic through single intraperitoneal alloxan injections (120 mg/kg body weight). They were then divided into 5 batches of ten rats each. The first batch was treated with A. annua leaf extract only. The second batch was treated with a combination of A. annua and M. charantia extracts. The third batch was treated with a combination of A. annua and V. amygdalina extracts while the fourth batch was treated with a combination of A. annua and Aegle marmelos extracts. The extracts were used in the ratio of 1:1 and treatment was done twice daily for a period of 30 days. The fifth batch of diabetic rats was not treated and thus served as control. The sixth batch of non-diabetic rats (10) was set up for comparison. Both the A. annua extract and its various combinations with the other experimental plant extracts resulted in insulin level enhancements and fasting blood glucose level reductions of the diabetic rats. There were significant differences (P≤0.05) in the insulin level of diabetic rats treated with A. annua leaf extract alone and those treated with different combinations of the plant extracts. The mean effects of the extracts on insulin and fasting blood glucose levels were most significant in A. annua + M. charantia (38.65 µlU/ml and 87.55 mg/dl) and A. annua + A. marmelos (38.55 µlU/ml and 87.92 mg/dl) treatments at P≤0.05. The non-treated diabetic rats had an average body weight of 94.90 g as compared to the original average body weight of 100 g at the commencement of the study. The treated diabetic rats had average body weight increments from 108.83g to 109.29 g. The non-diabetic rats had an average body weight of 114.10 g as compared to their initial average body weight of 100 g. The experimental plants were found to contain various biochemical constituents which were probably responsible for the blood serum insulin level enhancements and fasting blood glucose level reductions. The results obtained have shown that the A. annua leaf extract and its combinations with the other plant extracts could be employed in the management of hyperglycemia. The results have shown how effective A. annua var. chiknensis extract is in terms of lowering the blood glucose level or in the prevention of hyperglycemia. The results have also revealed that such blood glucose level reduction could be enhanced when the said extract is used in combination with other plant extracts that have similar effects in terms of management of hyperglycemia. It is hoped that new diabetes drugs that stem from the findings can be developed. However, in order to minimize the risk of diabetes cases in Nigeria, both conventional and traditional preventive measures should be considered.

Author(s) Details

Prof. Chike I. C. Ogbonna
Applied Microbiology and Biotechnology Research Unit, Department of Plant Science and Biotechnology, University of Jos, Nigeria.

Dr. (Mrs) Abigail. I. Ogbonna
Applied Microbiology and Biotechnology Research Unit, Department of Plant Science and Biotechnology, University of Jos, Nigeria.

Comments

Popular posts from this blog

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)

Ethnopharmacological Survey among Traditional Medicine Practitioners in Abidjan (Côte d'Ivoire) for the Management of Pathologies such as Malaria, ENT Diseases, Diarrhea, Typhoid Fever and Anemia | Chapter 05 | New Horizons in Medicine and Medical Research Vol. 8

 Traditional Medicine Practitioners (TMPs) of Côte d'Ivoire are familiar with the therapeutic herbs. Medicinal plants have been shown to be useful in the treatment of common diseases such as malaria (KROA, 2004) and diabetes (N'GUESSAN et al, 2013) in several studies and scientific study. In the Abidjan District, the current policy is to integrate traditional medicine and pharmacopoeia into the national health system in order to improve population health coverage, particularly in the management of commonly encountered diseases such as malaria, ENT diseases, diarrhoea, typhoid fever, and anaemia. This research aims to increase the use of traditional medicine and pharmacopoeia in the national health system. Over the course of three months, fifty (50) PMTs in the District of Abidjan participated in this study. Plant therapists accounted for 30 of the 50 PMTs polled at the end of the study, or 60%. Traditional medicine centres use 61 types of medicinal plants from 36 famili